Last Updated:
4:10 pm
Friday, June 20, 2025
Syntara Ltd. is a pharmaceutical research company, which engages in the development and commercialization of healthcare products for fibrotic and inflammatory diseases. Its respiratory products include bronchitol and aridol. The company was founded by Brett Charlton and William B. Cowden on May 29, 1998 and is headquartered in Sydney, Australia.
asx-snt
Market Cap
AU$110.48M
Volume
7789830
Open
0.05
AU$
High
0.05
AU$
Low
0.05
AU$
Shares On Issue
1.51B
52 Week Low
0.022
AU$
52 Week High
0.095
AU$
Website
www.pharmaxis.com.au
Consensus
N/A
Last Report Date
N/A
Next Report Date
N/A
Next Dividend date
N/A
Short Sell
N/A
Short Sell Change (1mth)
N/A
Free ASX Market Outlook & Top Stock Picks for 2025
Instantly access our exclusive report and see which stocks our analysts are backing for growth this year.
Download Free Report
Related
Our friendly team is here to help.
If you have any questions or feedback about our service, please feel free to contact us.
© Australian Stock Report Pty Ltd. All rights reserved